/

/

Share this news:

Share this news:

Psychedelic Drug DMT Shows Promise in Healing Brain After Stroke

Psychedelic Drug DMT Shows Promise in Healing Brain After Stroke

A new study reveals that DMT, a natural psychoactive compound, can significantly reduce stroke-induced brain damage by restoring the blood-brain barrier and curbing inflammation.

High resolution illustration showing the neuroprotective effects of a compound on brain tissue post-stroke.

Source:

Nature

A Psychedelic's Healing Potential

Scientists have uncovered a promising new role for a well-known psychedelic compound in brain recovery following a stroke. A recent study published in Science Advances reveals that DMT (Dimethyltryptamine) can significantly reduce brain damage in both animal and cell models.

The research, conducted by a team from the HUN-REN BRC Institute of Biophysics and Semmelweis University, highlights two key benefits.

Key Discoveries

  • Barrier Restoration: DMT was found to help repair the blood-brain barrier, a critical defense mechanism for the brain.

  • Inflammation Control: The compound effectively reduces neuroinflammation, a major cause of secondary damage after a stroke.

These findings suggest DMT could become a vital tool in improving outcomes for stroke survivors.

Keep up with the story. Subscribe to the PR+ free daily newsletter

Scientific visual of a brain model with highlighted stroke-affected areas, illustrating therapeutic application.

Source:

http://ScienceDirect.com

How DMT Protects the Brain

The therapeutic effects of DMT appear to stem from a dual-action mechanism that addresses stroke damage on multiple fronts.

Restoring a Critical Shield

A stroke can compromise the blood-brain barrier (BBB), leaving the brain vulnerable. The study found that DMT acts on Sigma-1 receptors to support the astroglial cells responsible for maintaining the BBB's structure and function. This helps restore the protective shield around the brain.

Calming Inflammation

Brain swelling and inflammation are common and dangerous consequences of a stroke. DMT was shown to inhibit the production of proinflammatory cytokines and limit the activation of microglia, the brain's primary immune cells. This targeted anti-inflammatory action helps prevent further neuronal damage.

"DMT acts through Sigma-1 receptors to limit microglial activation and support astroglial cells, creating a dual protective effect," one of the researchers noted.

Detailed graphical representation of DMT’s impact on brain function and recovery pathways.

Source:

Frontiers

From Lab to Clinical Care

Current treatments for stroke are limited, and many patients do not achieve a full recovery. This reality drives the search for innovative therapies that can be used alongside existing methods.

An Adjuvant Therapy

DMT is not seen as a replacement for current treatments but as a powerful adjuvant therapy. By repairing the BBB and reducing inflammation, it could complement established treatments like thrombolysis and thrombectomy, potentially transforming recovery outcomes for patients.

The Path Forward

The promising results have paved the way for human trials. Researchers are planning to launch Phase 2 clinical trials later in 2025 to evaluate the safety and efficacy of DMT in stroke patients.

Public interest is high, with many questions focusing on the treatment's safety, long-term effects, and eventual accessibility. These trials will be the next critical step in determining if this psychedelic compound can become a mainstream medical treatment for one of the leading causes of disability and death worldwide.

From Lab to Clinical Care

Current treatments for stroke are limited, and many patients do not achieve a full recovery. This reality drives the search for innovative therapies that can be used alongside existing methods.

An Adjuvant Therapy

DMT is not seen as a replacement for current treatments but as a powerful adjuvant therapy. By repairing the BBB and reducing inflammation, it could complement established treatments like thrombolysis and thrombectomy, potentially transforming recovery outcomes for patients.

The Path Forward

The promising results have paved the way for human trials. Researchers are planning to launch Phase 2 clinical trials later in 2025 to evaluate the safety and efficacy of DMT in stroke patients.

Public interest is high, with many questions focusing on the treatment's safety, long-term effects, and eventual accessibility. These trials will be the next critical step in determining if this psychedelic compound can become a mainstream medical treatment for one of the leading causes of disability and death worldwide.

How does DMT specifically restore the blood-brain barrier?

DMT helps restore the blood-brain barrier by acting through Sigma-1 receptors. This mechanism supports astroglial cells, which are essential for maintaining the barrier's integrity and function, thereby protecting the brain from harmful substances that could enter after a stroke.

How does DMT specifically restore the blood-brain barrier?

DMT helps restore the blood-brain barrier by acting through Sigma-1 receptors. This mechanism supports astroglial cells, which are essential for maintaining the barrier's integrity and function, thereby protecting the brain from harmful substances that could enter after a stroke.

How does DMT specifically restore the blood-brain barrier?

DMT helps restore the blood-brain barrier by acting through Sigma-1 receptors. This mechanism supports astroglial cells, which are essential for maintaining the barrier's integrity and function, thereby protecting the brain from harmful substances that could enter after a stroke.

What are the potential side effects of using DMT for stroke treatment?

What are the potential side effects of using DMT for stroke treatment?

What are the potential side effects of using DMT for stroke treatment?

How does DMT compare to other potential stroke treatments?

How does DMT compare to other potential stroke treatments?

How does DMT compare to other potential stroke treatments?

Are there any ethical concerns with using DMT in stroke patients?

Are there any ethical concerns with using DMT in stroke patients?

Are there any ethical concerns with using DMT in stroke patients?

What are the next steps for DMT in clinical trials for stroke treatment?

What are the next steps for DMT in clinical trials for stroke treatment?

What are the next steps for DMT in clinical trials for stroke treatment?

Share this news: